Release of Generic Lunesta Will Result in Substantial Savings in MSAs

Lunesta, a sedative commonly prescribed to treat insomnia, recently became available in generic form. Preparing Medicare Set-aside allocation reports using generic pricing as opposed to brand pricing will produce a savings of $1.31 per pill. This will result in a substantial savings for our clients.

Importantly, FDA approved generic drug products have to meet the same rigid standards as an innovator drug. All generic drugs approved by the FDA have been deemed to have the same quality, strength, purity and stability as brand-name drugs. In addition, the generic manufacturing, packaging, and testing sites must pass the same quality standards as those of brand-name drugs. Accordingly, we highly recommend that physicians who have been prescribing Lunesta as a brand be encouraged to consider prescribing the new, much more cost-effective generic instead.